CD4 and COVID-19: The proportion of clonally expanded CD4_Ef increased in moderate disease compared to healthy and severe group (Fig. 3d and Supplementary Table 4), suggesting that efficient clonal expansion of CD4_Ef might contribute to the prevention of serious COVID-19.